Ticker brief
HELP
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
14
authors 14d
8
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-06-23 → 2026-07-02 · now +0.00 (−1 bearish … +1 bullish)
Who spoke8
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @PrismMarketView | C | · | 3 | +0.18 |
| @CrweWorld | C | · | 2 | -0.05 |
| @OpenOutcrier | C | · | 2 | +0.03 |
| @BiopharmIQ | B | · | 2 | +0.20 |
| @theflynews | C | · | 2 | +0.10 |
| @jom2jp | C | -0.82 | 1 | +0.00 |
| @BioStocks | C | -0.39 | 1 | -0.10 |
| @Greatstockpix | C | -0.61 | 1 | +0.00 |
Recent signals14of 14 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-07-02 | @theflynews | +0.00 | Helus Pharma reports FY26 financial results but no numbers or direction in tweet. | · | tweet ↗ |
| 2026-06-29 | @PrismMarketView | -0.10 | HELP reported FY2026 net loss of $148M and Q4 2026 Phase 3 readout remains on track. | · | tweet ↗ |
| 2026-06-27 | @theflynews | +0.20 | Definium soars on study results; Helus enrollment progressing as planned. | · | tweet ↗ |
| 2026-06-27 | @BiopharmIQ | +0.20 | Weekly biotech move list with percentage gainers and losers, capped to six tickers. | · | tweet ↗ |
| 2026-06-25 | @Greatstockpix | +0.00 | Day trading watch list names multiple tickers for June 26 without entry intent. | · | tweet ↗ |
| 2026-06-25 | @PrismMarketView | +0.40 | Reports mid-day movers with percentage gains and losses for listed small-cap names. | · | tweet ↗ |
| 2026-06-25 | @BiopharmIQ | +0.20 | Biotech open news list with price moves and company catalysts, capped to six tickers. | · | tweet ↗ |
| 2026-06-24 | @PrismMarketView | +0.25 | HELP says Phase 3 enrollment is on schedule with topline data expected Q4 2026. | · | tweet ↗ |
| 2026-06-24 | @OpenOutcrier | -0.25 | Helus Pharma announces US$50M underwritten offering. | · | tweet ↗ |
| 2026-06-24 | @OpenOutcrier | +0.30 | Helus Pharma says Phase 3 depression trial is 86% enrolled. | · | tweet ↗ |
| 2026-06-24 | @CrweWorld | -0.20 | Helus Pharma announces US$50M underwritten offering. | · | tweet ↗ |
| 2026-06-24 | @CrweWorld | +0.10 | Helus Pharma updates APPROACH Phase 3 trial enrollment progress. | · | tweet ↗ |
| 2026-06-24 | @BioStocks | -0.10 | HELP prices $50M offering at $4.85/share. | · | tweet ↗ |
| 2026-06-23 | @jom2jp | +0.00 | Lists depression-treatment related stocks. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.